BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim SH, Shin YM, Yoo JY, Cho JY, Kang H, Lee H, Choe KH, Lee KM, Yang B. Clinical Factors Associated with Cavitary Tuberculosis and Its Treatment Outcomes. J Pers Med 2021;11:1081. [PMID: 34834433 DOI: 10.3390/jpm11111081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Anaam MS, Alrasheedy AA. Recurrence Rate of Pulmonary Tuberculosis in Patients Treated with the Standard 6-Month Regimen: Findings and Implications from a Prospective Observational Multicenter Study. Trop Med Infect Dis 2023;8. [PMID: 36828526 DOI: 10.3390/tropicalmed8020110] [Reference Citation Analysis]
2 岳 阳. Research Progress of Cavitary Pulmonary Tuberculosis. ACM 2023;13:3228-3233. [DOI: 10.12677/acm.2023.133459] [Reference Citation Analysis]
3 Abilbayeva A, Tarabayeva A, Myrkassymova A, Abubakirov A, Khaertynova I, Shuralev E. Factors associated with fibro-cavernous tuberculosis. J CLIN MED KAZ 2022;19:28-33. [DOI: 10.23950/jcmk/12504] [Reference Citation Analysis]
4 Wei R, Li P, Xue Y, Liu Y, Gong W, Zhao W. Impact of Diabetes Mellitus on the Immunity of Tuberculosis Patients: A Retrospective, Cross-Sectional Study. RMHP 2022;Volume 15:611-27. [DOI: 10.2147/rmhp.s354377] [Cited by in F6Publishing: 1] [Reference Citation Analysis]